{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:07:09Z","timestamp":1777997229901,"version":"3.51.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1177\/1933719111404612","type":"journal-article","created":{"date-parts":[[2011,6,21]],"date-time":"2011-06-21T02:46:29Z","timestamp":1308624389000},"page":"602-613","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Low Molecular Weight Heparin in Obstetric Care: A Review of the Literature"],"prefix":"10.1007","volume":"18","author":[{"given":"Silvia","family":"D\u2019Ippolito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amparo Santamaria","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Veglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Tersigni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Di Simone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,31]]},"reference":[{"issue":"17","key":"18070602_CR1","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1056\/NEJMe1002592","volume":"362","author":"IA Greer","year":"2010","unstructured":"Greer IA. Antithrombotic therapy for recurrent miscarriage. N Engl J Med. 2010;362(17):1630\u20131631.","journal-title":"N Engl J Med"},{"issue":"suppl3","key":"18070602_CR2","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/S0049-3848(09)70128-8","volume":"123","author":"I Pabinger","year":"2009","unstructured":"Pabinger I. Thrombophilia and its impact on pregnancy. Thromb Res. 2009;123(suppl 3):S16\u2013S21.","journal-title":"Thromb Res"},{"issue":"2","key":"18070602_CR3","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.ajog.2004.03.001","volume":"191","author":"JL Kujovich","year":"2004","unstructured":"Kujovich JL. Thrombophilia and pregnancy complications. Am J Obstet Gynecol. 2004;191(2):412\u2013424.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"18070602_CR4","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/j.thromres.2009.06.031","volume":"124","author":"F Lussana","year":"2009","unstructured":"Lussana F, Dentali F, Abbate R, et al. Screening for thrombophilia and antithrombotic prophylaxis in pregnancy: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res. 2009;124(5):e19\u2013e25.","journal-title":"Thromb Res"},{"issue":"4","key":"18070602_CR5","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1538-7836.2008.02921.x","volume":"6","author":"ER Pomp","year":"2008","unstructured":"Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJ. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost. 2008;6(4):632\u2013637.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"18070602_CR6","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1056\/NEJM200002103420602","volume":"342","author":"A Gerhardt","year":"2000","unstructured":"Gerhardt A, Scharf RE, Beckmann MW, et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med. 2000;342(6):374\u2013380.","journal-title":"N Engl J Med"},{"issue":"suppl1","key":"18070602_CR7","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1538-7836.2007.02501.x","volume":"5","author":"S Middeldorp","year":"2007","unstructured":"Middeldorp S. Thrombophilia and pregnancy complications: cause or association? J Thromb Haemost. 2007;5(suppl 1):276\u2013582.","journal-title":"J Thromb Haemost"},{"issue":"3","key":"18070602_CR8","first-page":"800","volume":"86","author":"I Martinelli","year":"2001","unstructured":"Martinelli I, Legnani C, Bucciarelli P, Grandone E, De Stefano V, Mannucci PM. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Thromb Haemost. 2001;86(3):800\u2013803.","journal-title":"Thromb Haemost"},{"issue":"9032","key":"18070602_CR9","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0140-6736(96)04125-6","volume":"348","author":"FE Preston","year":"1996","unstructured":"Preston FE, Rosendaal FR, Walker ID, et al. EPCOT study: increased fetal loss in women with heritable thrombophilia. Lancet. 1996;348(9032):913\u2013916.","journal-title":"Lancet"},{"issue":"1","key":"18070602_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJM199901073400102","volume":"340","author":"MJ Kupferminc","year":"1999","unstructured":"Kupferminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med. 1999;340(1):9\u201313.","journal-title":"N Engl J Med"},{"issue":"1","key":"18070602_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0301-2115(01)00496-1","volume":"101","author":"Z Alfirevic","year":"2002","unstructured":"Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophila and adverse pregnancy outcome) A systematic review. Eur J Obstet Gynecol Reprod Biol. 2002;101(1):6\u201314.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"18070602_CR12","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1160\/TH03-10-0637","volume":"91","author":"TE Dudding","year":"2004","unstructured":"Dudding TE, Attia J. The association between adverse pregnancy outcomes and maternal factor V Leiden gentype: a meta-analysis. Thromb Haemost. 2004;91(4):700\u2013711.","journal-title":"Thromb Haemost"},{"issue":"6","key":"18070602_CR13","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1161\/01.HYP.0000188979.74172.4d","volume":"46","author":"G Mello","year":"2005","unstructured":"Mello G, Parretti E, Marozio L, et al. Thrombophilia is significantly associated with severe preeclampsia. Results of a large-scale, case-controlled study. Hypertension. 2005;46(6):1270\u20131274.","journal-title":"Hypertension"},{"issue":"2","key":"18070602_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1365-2141.2005.05847.x","volume":"132","author":"L Robertson","year":"2005","unstructured":"Robertson L, Wu O, Langhorne P, et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol. 2005;132(2):171\u2013196.","journal-title":"Br J Haematol"},{"issue":"11","key":"18070602_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta10110","volume":"10","author":"O Wu","year":"2006","unstructured":"Wu O, Robertson L, Twaddle S, et al. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Trhombosis: risk and economic assessment of thrmobophilia screening (TREATS) study. Health Technol Assess. 2006;10(11):1\u2013110.","journal-title":"Health Technol Assess"},{"issue":"7","key":"18070602_CR16","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1097\/00004872-200307000-00002","volume":"21","author":"IP Kosmas","year":"2003","unstructured":"Kosmas IP, Tatsioni A, Ioannidis JP. Association of Leiden mutation in factor V gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis. J Hypertens. 2003;21(7):1121\u20131128.","journal-title":"J Hypertens"},{"issue":"2","key":"18070602_CR17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2141.2007.06902.x","volume":"140","author":"P Clark","year":"2008","unstructured":"Clark P, Walker ID, Govan L, Wu O, Greer IA. The GOAL study: a prospective examination of the impact of factor V Leiden and ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes. Br J Haematol. 2008;140(2):236\u2013240.","journal-title":"Br J Haematol"},{"issue":"1","key":"18070602_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/AOG.0b013e3181c88918","volume":"115","author":"RM Silver","year":"2010","unstructured":"Silver RM, Zhao Y, Spong CY, et al. Prothrombin gene G20210A mutation and obstetric complications. Obstet Gynecol. 2010;115(1):14\u201320.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"18070602_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1477-7827-1-111","volume":"14","author":"MJ Kupferminc","year":"2003","unstructured":"Kupferminc MJ. Thrombophilia and pregnancy. Reprod Biol Edocrinol. 2003;14(1):111.","journal-title":"Reprod Biol Edocrinol"},{"issue":"5","key":"18070602_CR20","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/j.1538-7836.2004.00822.x","volume":"2","author":"PS Wells","year":"2004","unstructured":"Wells PS, Rodger MA. Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications. J Thromb Haemost. 2004;2(5):1188\u20131190.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"18070602_CR21","first-page":"1333","volume":"101","author":"DW Branch","year":"2003","unstructured":"Branch DW, Khamashta MA. Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. Obstet Gynecol. 2003;101(6):1333\u20131344.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"18070602_CR22","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/0002-9378(92)91596-3","volume":"166","author":"FS Cowchock","year":"1992","unstructured":"Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol. 1992;166(5):1318\u20131323.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"18070602_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295\u2013306.","journal-title":"J Thromb Haemost"},{"issue":"7","key":"18070602_CR24","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1002\/art.22663","volume":"56","author":"D Erkan","year":"2007","unstructured":"Erkan D, Harrison MJ, Levy R, et al. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum. 2007;56(7):2382\u201323891.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"18070602_CR25","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/humupd\/dmn031","volume":"14","author":"SM Nelson","year":"2008","unstructured":"Nelson SM, Greer IA. The potential role of heparin in assisted conception. Hum Reprod Update. 2008;14(6):623\u2013645.","journal-title":"Hum Reprod Update"},{"issue":"5","key":"18070602_CR26","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1055\/s-0037-1613894","volume":"83","author":"B Brenner","year":"2000","unstructured":"Brenner B, Hoffmann R, Blumenfeld Z, Weiner Z, Younis JS. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb Haemost. 2000;83(5):693\u2013697.","journal-title":"Thromb Haemost"},{"issue":"1","key":"18070602_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3109\/10641950109152640","volume":"20","author":"MJ Kupferminc","year":"2001","unstructured":"Kupferminc MJ, Fait G, Many A, et al. Low molecular weight heparin for the prevention of obstetric complications in women with thrombophilias. Hypert Pregnancy. 2001;20(1):35\u201344.","journal-title":"Hypert Pregnancy"},{"issue":"3","key":"18070602_CR28","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1046\/j.1538-7836.2003.00066.x","volume":"1","author":"H Carp","year":"2002","unstructured":"Carp H, Dolitzky M, Inbal A. Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia. J Thromb Haemost. 2002;1(3):433\u2013438.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"18070602_CR29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1538-7836.2004.01130.x","volume":"3","author":"JC Gris","year":"2005","unstructured":"Gris JC, Mares P. The long and winding road\u2026towards LMWH for pregnancy loss. J Thromb Haemost. 2005;3(4):224\u2013226.","journal-title":"J Thromb Haemost"},{"issue":"10","key":"18070602_CR30","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1182\/blood-2003-12-4250","volume":"103","author":"JC Gris","year":"2004","unstructured":"Gris JC, Mercier E, Quer\u00e8 I, et al. Low-molecular weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood. 2004;103(10):3695\u20133699.","journal-title":"Blood"},{"issue":"2","key":"18070602_CR31","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0015-0282(02)03222-3","volume":"78","author":"E Grandone","year":"2002","unstructured":"Grandone E, Brancaccio V, Colaizzo D, et al. Preventig adverse obstetric outcomes in women weith genetic thrombophilia. Fertil Steril. 2002;78(2):371\u2013375.","journal-title":"Fertil Steril"},{"issue":"4","key":"18070602_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0049-3848(00)00413-8","volume":"101","author":"J Bar","year":"2001","unstructured":"Bar J, Mashiah R, Cohen-Sacher B, et al. Effect of thromboprophylaxis on uterine and fetal circulation in pregnant women with a history of pregnancy complications. Thromb Res. 2001;101(4):235\u2013241.","journal-title":"Thromb Res"},{"issue":"2","key":"18070602_CR33","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1538-7836.2004.01090.x","volume":"3","author":"B Brenner","year":"2005","unstructured":"Brenner B, Hoffmann R, Carp H, et al. Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. J Thromb Haemost. 2005;3(2):227\u2013229.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"18070602_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1538-7836.2005.01155.x","volume":"3","author":"PG Lindqvist","year":"2005","unstructured":"Lindqvist PG, Merlo J. Low molecular weight heparin for repeated pregnancy loss: is it based on solid evidence? Thromb Haemost. 2005;3(2):221\u2013223.","journal-title":"Thromb Haemost"},{"issue":"7057","key":"18070602_CR35","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1136\/bmj.313.7057.570","volume":"313","author":"DG Altman","year":"1996","unstructured":"Altman DG. Better reporting of randomised controlled trials: the CONSORT statement. BMJ. 1996;313(7057):570\u2013571.","journal-title":"BMJ"},{"issue":"10","key":"18070602_CR36","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S1701-2163(16)32641-X","volume":"29","author":"L Leduc","year":"2007","unstructured":"Leduc L, Dubois E, Takser L, Rey E, David M. Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia. J Obstet Gynaecol Can. 2007;29(10):787\u2013793.","journal-title":"J Obstet Gynaecol Can"},{"issue":"1","key":"18070602_CR37","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1160\/TH06-10-0574","volume":"98","author":"K Abou-Nassar","year":"2007","unstructured":"Abou-Nassar K, Kovacs MJ, Kahn SR, et al. The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial. Thromb Haemost. 2007;98(1):163\u2013171.","journal-title":"Thromb Haemost"},{"issue":"3","key":"18070602_CR38","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/nm825","volume":"9","author":"B Isermann","year":"2003","unstructured":"Isermann B, Sood R, Pawlinski R, et al. Thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nat Med. 2003;9(3):258\u2013260.","journal-title":"Nat Med"},{"issue":"11","key":"18070602_CR39","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/nm1121","volume":"10","author":"G Girardi","year":"2004","unstructured":"Girardi G, Redecha B, Salmon JE. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med. 2004;10(11):1222\u20131226.","journal-title":"Nat Med"},{"issue":"2","key":"18070602_CR40","first-page":"135","volume":"42","author":"HA Mousa","year":"2001","unstructured":"Mousa HA, Alfirevi\u0107 Z. Thrombophilia and adverse pregnancy outcome. Croat Med J. 2001;42(2):135\u2013145.","journal-title":"Croat Med J"},{"issue":"2","key":"18070602_CR41","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/AOG.0b013e3181801d56","volume":"112","author":"JR Barton","year":"2008","unstructured":"Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol. 2008;112(2 pt 1):359\u2013372.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"18070602_CR42","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1182\/blood-2005-02-0626","volume":"106","author":"IA Greer","year":"2005","unstructured":"Greer IA, Nelson-Piercy C. Low-molecular weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood. 2005;106(2):401\u2013407.","journal-title":"Blood"},{"issue":"2","key":"18070602_CR43","first-page":"1","volume":"24","author":"ACOG.","year":"2001","unstructured":"ACOG. Management of recurrent pregnancy loss. Practice Bull. 2001;24(2):1\u201312.","journal-title":"Practice Bull"},{"issue":"2","key":"18070602_CR44","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.fertnstert.2005.12.068","volume":"86","author":"M Dolitzky","year":"2006","unstructured":"Dolitzky M, Inbal A, Segal Y, Weiss A, Brenner B, Carp H. A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriage. Fertil Steril. 2006;86(2):362\u2013366.","journal-title":"Fertil Steril"},{"issue":"1","key":"18070602_CR45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00404-007-0527-x","volume":"278","author":"M Fawzy","year":"2008","unstructured":"Fawzy M, Shokeir T, El-Tatongy M, Warda O, El-Refaiey AA, Mosbah A. Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study. Arch Gynecol Obstet. 2008;278(1):33\u201338.","journal-title":"Arch Gynecol Obstet"},{"issue":"17","key":"18070602_CR46","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1056\/NEJMoa1000641","volume":"362","author":"SP Kaandorp","year":"2010","unstructured":"Kaandorp SP, Goddijn M, Van der Post JAM. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med. 2010;362(17):1586\u20131596.","journal-title":"N Engl J Med"},{"issue":"1","key":"18070602_CR47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ajog.2004.09.029","volume":"192","author":"P Bose","year":"2005","unstructured":"Bose P, Black S, Kadyrov M, et al. Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure. Am J Obstet Gynecol. 2005;192(1):23\u201330.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"18070602_CR48","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/art.27361","volume":"62","author":"N Di Simone","year":"2010","unstructured":"Di Simone N, Marana R, Castellani R, et al. Decreased expression of heparin-binding epidermal growth factor-like growth factor as a newly identified pathogenic mechanism of antiphospholipid-mediated defective placentation. Arthritis Rheum. 2010;62(5):1504\u20131512.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"18070602_CR49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jri.2005.01.006","volume":"66","author":"G Girardi","year":"2005","unstructured":"Girardi G. Heparin treatment in pregnancy loss: potential therapeutic benefits beyond anticoagulation. J Reprod Immunol. 2005;66(1):45\u201351.","journal-title":"J Reprod Immunol"},{"issue":"1","key":"18070602_CR50","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1365-2141.2006.05959.x","volume":"133","author":"H Hochart","year":"2006","unstructured":"Hochart H, Jenkins PV, Smith OP, White B. Low-molecular weight and unfractionated heparins induce a downregulation of inflammation: decreased levels of proinflammatory cytokines and nuclear factor-kappaB in LPS-stimulated human monocytes. Br J Haematol. 2006;133(1):62\u201367.","journal-title":"Br J Haematol"},{"issue":"1","key":"18070602_CR51","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1136\/gut.47.1.88","volume":"47","author":"A Salas","year":"2000","unstructured":"Salas A, Sans M, Soriano A, et al. Heparin attenuates TNF-alpha induced inflammatory response through a CD11b dependent mechanism. Gut. 2000;47(1):88\u201396.","journal-title":"Gut"},{"issue":"2","key":"18070602_CR52","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.mam.2007.04.004","volume":"28","author":"B Schiessl","year":"2007","unstructured":"Schiessl B. Inflammatory response in preeclampsia. Mol Aspects Med. 2007;28(2):210\u2013219.","journal-title":"Mol Aspects Med"},{"issue":"5728","key":"18070602_CR53","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1126\/science.1111726","volume":"308","author":"CW Redman","year":"2005","unstructured":"Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308(5728):1592\u20131594.","journal-title":"Science"},{"issue":"1","key":"18070602_CR54","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1161\/01.HYP.0000149950.05182.a3","volume":"45","author":"G Mello","year":"2005","unstructured":"Mello G, Parretti E, Fatin C, et al. Low-molecular weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension. 2005;45(1):86\u201391.","journal-title":"Hypertension"},{"issue":"2","key":"18070602_CR55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/10641950600745517","volume":"25","author":"S Ferrazzani","year":"2006","unstructured":"Ferrazzani S, D\u2019Alessio MC, Fatigante G. Prophylaxis of recurrent preeclampsia: low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin alone. Hypertens Pregnancy. 2006;25(2):115\u2013127.","journal-title":"Hypertens Pregnancy"},{"issue":"9341","key":"18070602_CR56","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/S0140-6736(02)11283-9","volume":"360","author":"RE Leach","year":"2002","unstructured":"Leach RE, Romero R, Kim YM, et al. Pre-eclampsia and expression of heparin-binding EGF-like growth factor. Lancet. 2002;360(9341):1215\u20131219.","journal-title":"Lancet"},{"issue":"4","key":"18070602_CR57","doi-asserted-by":"publisher","first-page":"471.e1","DOI":"10.1016\/j.ajog.2008.01.009","volume":"198","author":"RE Leach","year":"2008","unstructured":"Leach RE, Kilburn BA, Petkova A, Romero R, Armant DR. Diminished survival of human cytotrophoblast cells exposed to hypoxia\/reoxygenation injury and associated reduction of heparin-binding epidermal growth factor-like growth factor. Am J Obstet Gynecol. 2008;198(4):471.e1\u2013e7.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"18070602_CR58","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1538-7836.2008.03230.x","volume":"7","author":"E Rey","year":"2009","unstructured":"Rey E, Garneau P, David M, et al. Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophila: a pilot randomized controlled trial. J Thromb Haemost. 2009;7(1):58\u201364.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"18070602_CR59","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1160\/TH06-10-0606","volume":"97","author":"A Kher","year":"2007","unstructured":"Kher A, Bauersachs R, Nielsen JD. The management of thrombosis in pregnancy: role of low molecular weight heparin. Thromb Haemost. 2007;97(4):505\u2013513.","journal-title":"Thromb Haemost"},{"issue":"1","key":"18070602_CR60","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0961203309353171","volume":"19","author":"E Lekfou","year":"2010","unstructured":"Lekfou E, Khamashta M, Hampson G, Hunt BJ. Low molecular weight heparin induced osteoporosis and osteoporotic fractures: a myth or existing entity? Lupus. 2010;19(1):3\u201312.","journal-title":"Lupus"},{"issue":"9","key":"18070602_CR61","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1093\/humrep\/del150","volume":"21","author":"E Janiaux","year":"2006","unstructured":"Janiaux E, Farquarson RG, Christinasen OB, Exalto N. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod. 2006;21(9):2216\u20132222.","journal-title":"Hum Reprod"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719111404612.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1933719111404612","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1177\/1933719111404612\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1933719111404612","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719111404612.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T21:00:21Z","timestamp":1712523621000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1177\/1933719111404612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":61,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["18070602"],"URL":"https:\/\/doi.org\/10.1177\/1933719111404612","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"31 December 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}